Dynamic Duo Seminar Series: "Response and Resistance to targeted inhibitors in melanoma"

Document Type

Presentation

Loading...

Media is loading
 

Publication Date

12-1-2016

Abstract

Berger presentation overview:

Background

  • Melanoma epidemic
  • Survival Statistics
  • Sentinel node biopsy/MSLT-1

Current Advances

  • GEP
  • Targeted therapy
  • Immunotherapy

Future Directions/Translational Work

Dr. Aplin's presentation is titled:

  • Response and resistance to targeted therapies in melanoma

Presentation: 44:73

End of presentation continues here (last 06:73)

This document is currently not available here.

Share

COinS